• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Biogen Idec Inc. (BIIB)

    -NasdaqGS
    360.67 Up 6.97(1.97%) Dec 19, 4:00PM EST
    |After Hours : 362.80 Up 2.13 (0.59%) Dec 19, 7:58PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:377.48
    Median Target:382.00
    High Target:474.00
    Low Target:285.00
    No. of Brokers:21

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 22, 2014Robert W. BairdUpgradeNeutralOutperform
    Oct 30, 2013FBR CapitalInitiated Mkt Perform
    Dec 18, 2012Canaccord GenuityInitiated Hold
    Oct 5, 2012OppenheimerDowngradeOutperformPerform
    Sep 10, 2012UBSDowngradeBuyNeutral
    Dec 9, 2011Barclays CapitalInitiated Overweight
    Sep 9, 2011UBSUpgradeNeutralBuy
    Aug 18, 2011OppenheimerUpgradePerformOutperform
    Jun 21, 2011Deutsche BankUpgradeHoldBuy
    Apr 15, 2011MP AdvisorsUpgradeMarket PerformOutperform

    More Upgrades & Downgrades for BIIB

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0655
    Buy0101010
    Hold0898
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.